Publication | Open Access
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study
19
Citations
24
References
2023
Year
Our findings suggest that the combination of low sPD-1 and high sPD-L1 levels is a potential negative biomarker for PD-1 blockade therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1